Pulmonary Hypertension and VTE Learning Pathway
What does a cardiologist really need to know about the diagnosis of pulmonary arterial hypertension? What is new and controversial in the management of pulmonary embolism and deep vein thrombosis, and what are the updated management recommendations for pulmonary hypertension from the 6th World Symposium in Nice? These questions and more will be addressed in the Pulmonary Hypertension and Venous Thrombo-embolic (VTE) Learning Pathway.
The short but powerful program seeks to demystify the diagnosis of pulmonary arterial hypertension, debate core management issues related to pulmonary hypertension, and address new and controversial management issues with the goal of enabling attendees to define best practice in caring for their patients.
Many sessions represent a true multidisciplinary approach and provide a broad spectrum look at pulmonary hypertension and VTE. Not just specialists, but general cardiologists, heart failure specialists, vascular specialists and other cardiovascular care team members will find these sessions filled with information that will help them advance and elevate their care of patients with pulmonary hypertension and VTE.
- The Many Faces of Pulmonary Hypertension: Patient and Physician Perspectives on Congenital Heart Disease, Heart Failure Preserved Ejection Fraction and Chronic Thromboembolic Pulmonary Hypertension (Session #618)
- Demystifying the Diagnosis of Pulmonary Arterial Hypertension: What Does a Cardiologist Really Need to Know? (Session #702)
- What's New and Controversial in VTE Management (Session #725)
- Not All Pulmonary Hypertension is Pulmonary Arterial Hypertension (Session #755)
- Highlighted Original Research: Pulmonary Hypertension and Venous Thrombo-embolic Disease and the Year in Review (Session #902)
| 2018 American College of Cardiology Foundation. Visit ACC.org|